Rare diseases
Investigational molecules
Locations
Back to Greece1 clinical trial in Argos-Mykines, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
GreeceThe busiest research cities in the country
What the registry says about research in the country
In Argos-Mykines, two actively recruiting studies are centered on innovative approaches to treat Major Depressive Disorder, aiming to expand therapeutic options for patients with persistent depressive symptoms.
Conducted at the city’s single research site and led by two investigators, these trials seek to determine whether adding brenipatide to existing medication regimens offers a superior benefit over placebo for individuals suffering from major depression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
